Barium

Overview

Barium is under investigation for the diagnostic of Known or Suspected Abdominal Disease.

Barium is under investigation for the diagnostic of Known or Suspected Abdominal Disease.

No indication information available.

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor
Physiological Study of the Human CYP3A Activity (PiSA)	2017/07/02	NCT03204578	Phase 4	Completed	University Hospital, Basel, Switzerland
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy	2016/01/26	NCT02662907	Not Applicable	Active, not recruiting	M.D. Anderson Cancer Center
Uniformity of Oral Contrast Material in the Bowel	2015/09/04	NCT02542046	N/A	Completed	University of California, San Francisco
Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients	2014/06/24	NCT02172352	Phase 2	Completed	Boehringer Ingelheim
Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)	2006/06/30	NCT00346502	Phase 1	Withdrawn	University of Illinois at Chicago
A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)	2006/02/16	NCT00292448	Phase 2	Completed	Boehringer Ingelheim

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Bio Co Enzyme Phase	Deseret Biologicals, Inc.	43742-2259	ORAL	34 [hp_C] in 1 mL	4/8/2025
1 Bladder	The Wellness Center for Research and Education, Inc.	50181-0037	ORAL	1 [hp_X] in 1 mL	5/28/2025
Shame	Deseret Biologicals, Inc.	43742-2276	ORAL	12 [hp_X] in 1 mL	5/7/2025
Metox	Deseret Biologicals, Inc.	43742-1312	ORAL	12 [hp_X] in 1 mL	5/27/2025
Immuno-Boost	Parasitology Center, Inc.	70321-0002	ORAL	30 [hp_C] in 1 mL	5/22/2025
MetDetox	Dr. Donna Restivo DC	62185-0062	ORAL	12 [hp_X] in 1 mL	5/23/2025
MBM 1 BLADDER	The Wellness Center for Research and Education, Inc.	50181-0033	ORAL	144 [hp_C] in 1 mL	5/28/2025
Bestmade Natural Products BM84	Bestmade Natural Products	82969-2084	ORAL	30 [hp_C] in 30 [hp_C]	1/31/2025

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

No news found